International Biotechnology Trust PLC Merus N.V. Transaction History

International Biotechnology Trust PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.46 - $20.81 $860,187 - $1.56 Million	-75,060 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.47 - $26.39 $1.04 Million - $1.48 Million	56,261 Added 299.28%	75,060 $1.14 Million
Q3 2018 Nov 13, 2018	SELL	$18.47 - $26.39 $1.04 Million - $1.48 Million	-56,261 Reduced 74.95%	18,799 $257,000
Q1 2018 May 15, 2018	BUY	$16.07 - $19.87 $1.21 Million - $1.49 Million	75,060 New	75,060 $1.39 Million
Q3 2017 Mar 02, 2018	SELL	$13.6 - $19.87 $828,865 - $1.21 Million	-60,946 Closed	0 $0
Q2 2017 Mar 02, 2018	BUY	N/A	60,946	60,946 $966,000

203

62M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.86B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.